Nasdaq · Common stock
City Therapeutics (CTY)
$20.79 +$0.02 (+0.10%)
- Day’s range
- $20.30–$21.31
- Volume
- 136,056
CTY price history
CTY closed at $20.79 on Oct. 26, 2026. Over the past year, its daily close ranged from $20.43 on Oct. 21, 2026 to $22.40 on Oct. 16, 2026.
Data table: CTY daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $20.79 |
| Oct. 23, 2026 | $20.77 |
| Oct. 22, 2026 | $20.77 |
| Oct. 21, 2026 | $20.43 |
| Oct. 20, 2026 | $20.83 |
| Oct. 19, 2026 | $21.46 |
| Oct. 16, 2026 | $22.40 |
Key figures
- Average daily volume
- 461,271Past 3 months
- Market value
- $1.05B
- Dividend yield
- —
What Wall Street says about CTY
No Wall Street firm has published a rating or price-target change on CTY in the past 90 days.
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About City Therapeutics, Inc. Common Stock
City Therapeutics Inc is a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics designed to silence the expression of disease-relevant proteins. Its current pipeline is focused on indications with unmet medical need, including thromboembolic diseases, Stargardt disease type 1 (Stargardt disease), and anemia of chronic disease.
- Listed
- Oct. 16, 2026
In WallStreetDigest editions
No WallStreetDigest article about CTY is on the site yet.